Crescent Biopharma Income Statement (2013-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	0.09M	0.02M		0.07M															1.04M
Operating items
Research & Development (Quarter)	13.28M	12.90M	9.60M	7.97M	4.92M	5.89M	5.42M	4.07M	5.29M	5.29M	6.03M	6.29M	2.47M	0.15M	10.63M	12.08M	20.35M	78.20M	17.90M	19.39M
Selling, General & Administrative (Quarter)	4.14M	4.55M	5.06M	5.45M	3.84M	4.73M	5.52M	4.86M	4.52M	4.31M	5.09M	4.07M	4.01M	3.16M	3.60M	8.95M	5.54M	7.31M	7.87M	8.74M
Restructuring Costs (Quarter)													5.51M	2.02M
Other Operating Expenses (Quarter)													1.22M					16.83M		1.77M
Operating Expenses (Quarter)	17.42M	17.44M	14.66M	13.43M	8.77M	10.62M	10.94M	8.93M	9.81M	9.60M	11.12M	10.36M	11.23M	17.19M	14.22M	21.03M	25.89M	102.34M	25.77M	28.13M
Operating Income (Quarter)	-17.34M	-17.43M	-14.66M	-13.35M	-8.77M	-10.62M	-10.94M	-8.93M	-9.81M	-9.59M	-11.12M	-10.36M	-11.23M	-17.19M	-14.22M	-21.03M	-25.89M	-91.49M	-24.73M	-26.36M
EBIT (Quarter)	-17.34M	-17.43M	-14.66M	-13.35M	-8.77M	-10.62M	-10.94M	-8.93M	-9.81M	-9.59M	-11.12M	-10.36M	-11.23M	-17.19M	-14.22M	-21.03M	-25.89M	-91.49M	-24.73M	-26.36M
Non-operating items
Interest & Investment Income (Quarter)														0.18M	0.19M	0.31M	1.28M	1.09M	1.45M	1.53M
Other Non Operating Income (Quarter)															-0.92M	-0.76M	1.28M		1.45M	1.53M
Non Operating Income (Quarter)	0.00M	0.00M	0.01M	0.09M	0.24M	0.38M	0.58M	0.67M	0.61M	0.51M	0.38M	0.26M	1.41M	0.68M	1.15M				-1.45M	-3.30M
Net income details
EBT (Quarter)	-17.33M	-17.42M	-14.65M	-13.27M	-8.52M	-10.24M	-10.36M	-8.26M	-9.20M	-9.08M	-10.74M	-10.10M	-9.82M	-17.87M	-2.30M	-51.31M	-24.61M	-90.40M	-76.28M	-24.84M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-17.33M	-17.42M	-14.65M	-13.27M	-8.52M	-10.24M	-10.36M	-8.26M	-9.20M	-9.08M	-10.74M	-10.10M	-9.82M	-17.87M	-15.15M	-21.79M	-24.60M	-23.30M	-23.28M	-24.84M
Income from Continuing Operations (Quarter)	-17.33M	-17.42M	-14.65M	-13.27M	-8.52M	-10.24M	-10.36M	-8.26M	-9.20M	-9.08M	-10.74M	-10.10M	-9.82M	-17.87M	-2.30M	-51.31M	-24.61M	-90.40M	-76.28M	-24.84M
Consolidated Net Income (Quarter)	-17.33M	-17.42M	-14.65M	-13.27M	-8.52M	-10.24M	-10.36M	-8.26M	-9.20M	-9.08M	-10.74M	-10.10M	-9.82M	-17.87M	-2.30M	-51.31M	-24.61M	-90.40M	-76.28M	-24.84M
Income towards Parent Company (Quarter)	-17.33M	-17.42M	-14.65M	-13.27M	-8.52M	-10.24M	-10.36M	-8.26M	-9.20M	-9.08M	-10.74M	-10.10M	-9.82M	-17.87M	-2.30M	-51.31M	-24.61M	-90.40M	-76.28M	-24.84M
Net Income towards Common Stockholders (Quarter)	-17.33M	-17.42M	-14.65M	-13.27M	-8.52M	-10.24M	-10.36M	-8.26M	-9.20M	-9.08M	-10.74M	-10.10M	-9.82M	-17.87M	-2.30M	-51.31M	-24.61M	-90.40M	-76.28M	-24.84M
Additional items
EPS (Basic) (Quarter)	-33.61	-33.86	-28.00	-25.32	-16.26	-19.50	-17.17	-12.85	-14.30	-14.33	-16.66	-15.66	-15.24	-27.71	-3.56	-11.92	-5.32	-12.90	-10.89	-3.43
EPS (Diluted) (Quarter)	-33.61	-33.86	-28.00	-25.32	-16.26	-19.50	-17.17	-12.85	-14.30	-14.33	-16.66	-15.66	-15.24	-27.71	-3.57	-79.58	-38.16	-140.20	-118.31	-38.52
Shares Outstanding (Quarter)	0.52M	0.51M	0.52M	0.52M	0.52M	0.53M	0.60M	0.64M	0.64M	0.63M	0.64M	0.64M	0.64M	0.64M	0.65M	4.31M	4.63M	7.01M	7.00M	7.23M
Shares Outstanding (Diluted) (Quarter)	0.52M	0.51M	0.52M	0.52M	0.52M	0.53M	0.60M	0.64M	0.64M	0.63M	0.64M	0.64M	0.64M	0.64M	0.64M	0.64M	0.64M	0.64M	0.64M	0.64M
Shares Outstanding (Entity) (Quarter)	0.52M	0.52M	0.52M	0.52M	0.52M	0.54M	0.64M	0.64M	0.64M	0.64M	0.64M	0.64M	0.64M	0.64M	0.65M	4.31M	4.63M	7.01M	7.00M	7.23M
EBITDA (Quarter)	-17.34M	-17.43M	-14.66M	-13.35M	-8.77M	-10.62M	-10.94M	-8.93M	-9.81M	-9.59M	-11.12M	-10.36M	-11.23M	-17.19M	-14.22M	-21.03M	-25.89M	-91.49M	-24.73M	-26.36M
Interest Expenses (Quarter)	0.27M	0.27M	0.27M	0.27M	0.28M	0.28M	0.34M	1.04M	0.66M	0.17M	4.03M	0.46M	0.01M	0.85M	1.11M	30.59M			53.00M
Tax Rate (Quarter)

Research Tools

Datasets

Plans

Developers

Crescent Biopharma CBIO Income Statement (2013-2026)

Research Tools

Datasets

Plans

Developers

Crescent Biopharma CBIO Income Statement (2013-2026)

Create an account

Sign In

Reset Password